Nancy Kavanaugh has served in various regulatory roles supporting biological products and vaccines at MedImmune and then AstraZeneca since 2005 and currently serves as Senior Director, CMC Regulatory Affairs. Prior to MedImmune, Nancy spent eight years as Principal Consultant, Don Hill and Associates, providing quality and regulatory support to the biotech industry following a ten year career with FDA’s Center for Biologics Evaluation and Research as reviewer and inspector. Nancy holds a B.S, M.S. and Ph.D from the Catholic University of America in Washington, D.C. in Cell and Microbial Biology.